RxDoctor Payments Data

Macey Gettinger

Nurse Practitioner · Mount Vernon, ILNPI 1912528126

Payments from drug & device makers

$2,180in general payments, 2019–2025

Across 140 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$688
  • Novo Nordisk$425
  • AstraZeneca$224
  • Amgen$164
  • Lilly USA, LLC$123
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$121
  • plus $434 from 11 others

What the payments were for

  • Food & beverage$2,180100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,180 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$45,389
Medicare patients
104
Services billed
765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide50$75,729
OzempicSemaglutide33$53,311
LinzessLinaclotide52$45,834
EliquisApixaban23$22,886
XareltoRivaroxaban21$20,422
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$18,308
JardianceEmpagliflozin17$17,136
Breo ElliptaFluticasone/Vilanterol26$11,625
Nurtec OdtRimegepant Sulfate11$10,687
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen232$9,823
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$6,251
Asa-Butalb-Caffeine-CodeineCodeine/Butalbital/Asa/Caffein21$4,654
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen105$4,425
Pregabalin13$2,747
Albuterol Sulfate HfaAlbuterol Sulfate65$2,101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$123$75,72950 claims
Novo NordiskOzempic$425$53,31133 claims
AbbVieLinzess$688$45,83452 claims
GSKTrelegy Ellipta, Breo Ellipta$96$29,93341 claims
Johnson & JohnsonXarelto$46$20,42221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Mount Vernon

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →